HALOZYME THERAPEUTICS, INC.: operating_income

Value{"amount": -67610000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Period2019-01-01 – 2019-12-31
Statuscurrent
EntityHALOZYME THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001159036-20-000013
Retrieved: 2026-08-19T11:36:29.993166+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001159036/operating-income/2019-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e7db3fc0-f44b-4e37-b0ff-6daf55b4f197

History